[42A14-42A14];[42C7-42C7];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
42A14;42C7
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(2R)ED1618.
The presence of P+PBac{XP5.WH5}BSC326 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of P{XP}d04812 to be at Release 3 genomic coordinate 1374527 on chromosome arm 2R. This corresponds to 42A14 on both the Release 3 and 5 genome maps. The predicted position of PBac{WH}phtff01263 on the Release 5 map is 42C7. Consequently, the cytological breakpoints of Df(2R)BSC326 are predicted to be 42A14;42C7.